MAZE – maze therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Maze Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
Maze Therapeutics SVP Sells 5,000 Shares Amid Historic First Year for the Company's Stock [Yahoo! Finance]
Maze Therapeutics (NASDAQ:MAZE) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Maze Therapeutics (NASDAQ:MAZE) was upgraded by analysts at Wall Street
Maze Therapeutics (NASDAQ:MAZE) was downgraded by analysts at Wall Stree
Form SCHEDULE 13G/A Maze Therapeutics, Inc. Filed by: GV 2019, L.P.
Form S-8 Maze Therapeutics, Inc.
Form S-3ASR Maze Therapeutics, Inc.
Form 8-K Maze Therapeutics, Inc. For: Feb 02
Form 4 Maze Therapeutics, Inc. For: Feb 02 Filed by: Bernstein Harold
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.